@article{f7794e1a191644878ae8da33dd937324,
title = "Update on HER2-Positive Adjuvant Therapy",
author = "Reshma Mahtani and {Sandoval Leon}, {Ana Cristina} and Mohammad Jahanzeb",
note = "Introduction Breast cancer is a heterogeneous disease, with approximately 20% of breast cancers exhibiting amplification of the HER2 gene. 1 This gene was discovered more than 30 years ago and was recognized to confer a poor prognosis. 2-4 The approval of trastuzumab for the treatment of HER2-positive metastatic breast cancer in 1998 represented a major breakthrough for these patients.",
year = "2017",
language = "American English",
volume = "13",
journal = "AJHO",
}